Home > Press Room > Press Releases

Bioponic Phytoceuticals Signs Marketing Agreement With Truly Natural Marketing

 BPI

 

 

MAUI, HI--(Marketwire - July 22, 2008) - Bioponic Phytoceuticals, Inc. ("Bioponic" or "the Company") (PINKSHEETS: BPYT) announced today that it has signed a marketing agreement with Truly Natural Marketing ("Truly Natural"), a New Hampshire-based sales and marketing firm specializing in representing all-natural healing products to North American health food retailers. Truly Natural will market Bioponic's key product lines as part of the Company's national product roll-out strategy.
Over the past 15 years, Truly Natural has specialized in representing personal care and organic, all-natural healing products with clean ingredients and ecological packaging. Among the brands it has helped develop are: Burt's Bees; Ecco Bella; Indigo Wild; All Terrain; Parissa; PeaceKeeper Cause-Metics; and Baudelaire. The principal of Truly Natural, Sol Solomon, is a 30-year veteran of the natural products industry. Prior to founding Truly Natural, Solomon spent 15 years managing a distribution company for national and international brands, including: Aura Caci; Borlind of Germany; Dr. Hauschka; Boiron; Bach Flower Remedies; Mole Hollow Candles, and Hyland's Homeopathics.
"This agreement puts Bioponic products into the very capable hands of Sol Solomon, a true mastermind in creating national brands from the ground-up in the organic and natural products sector. Most notably, Sol helped create a market for Burt's Bees homemade personal care products, including their now famous lip balm. He helped the company achieve sales of $3 million within just two years in the late 1990s," said Steven M. Schorr, Chairman & CEO of Bioponic. "Sol is an experienced marketer that can help build our brand equity and set the foundation for us to significantly grow our retail product sales in 2008 and beyond."
"I am very pleased to partner with Bioponic for the first time to help create excitement and market awareness of the Company's distinct line of therapeutic and all-natural product offerings," said Sol Solomon.

Continue reading "Bioponic Phytoceuticals Signs Marketing Agreement With Truly Natural Marketing" »

Bioponic Phytoceuticals Appoints Renowned Physician Dr. Barbara Nabrit-Stephens to Scientific Advisory Board

KULA, MAUI, Hawaii, April 22 /PRNewswire-FirstCall/ --BPI logo

Bioponic Phytoceuticals, Inc. (OTC Bulletin Board: BPYT - News; "Bioponic" or "the Company") today announced that Dr. Barbara Anne Nabrit-Stephens, MD, MBA, FAAP has joined the Company's Scientific Advisory Board. Dr. Nabrit-Stephens is a board-certified pediatrician with over 30 years of health care experience. As a scientific advisor, Dr. Nabrit-Stephens will help validate and formulate Bioponic's strategies to market its all-natural therapeutic products, including Curecumin(TM) and Curmisinin(TM).

"We are honored to welcome Dr. Nabrit-Stephens to our Scientific Advisory Board. Dr. Nabrit-Stephens' in-depth experience as both a clinician and health care administrator is a true asset to our organization," said Steven M. Schorr, Chairman and CEO of Bioponic. "Testing and research programs for Alzheimer's applications for Curecumin(TM) and distribution of Curmisinin(TM) to treat the deadly cerebra malaria, which kills over 2 million children in Sub-Saharan Africa, are the first projects Dr. Nabrit-Stephens will be involved in. She is also ideally suited to advise us on our newest product line, Gentle Mother, specifically for the needs of newborns and infants."

Dr. Nabrit-Stephens said, "I've always been attracted to those companies who focus on providing pro-active healthcare solutions, especially to those populations at-risk. Bioponic's work in bringing all-natural treatments to control devastating malaria in Africa is very impressive. I believe Bioponic's Bioresonant formulations could potentially represent a breakthrough in the treatment of epidemic disease. I am intrigued to discover more about the Company and their product lines, and look forward to our ongoing collaboration."

Continue reading "Bioponic Phytoceuticals Appoints Renowned Physician Dr. Barbara Nabrit-Stephens to Scientific Advisory Board" »

Bioponic Phytoceuticals Announces Curecumin(TM) May Lower Heart Failure Risk

KULA, Maui, April 16 /PRNewswire/ -- Bioponic Phytoceuticals, Inc. (OTC: BPYT - News; "Bioponic" or "theCurecumin Company") today announced that curcumin, the key ingredient in the Company's Curecumin(TM) product (a Bioresonant Phytotherapeutic® form of curcumin in a liquid delivery system) may be an important treatment for lowering heart failure risk. Bioponic currently sells Curecumin in a 1 oz. oral spray and a 1 oz. nasal pump spray bottle. Research findings and product information on Curecumin's many therapeutic qualities can be found at http://www.curecumin.com.

In a recent study entitled, "Curcumin prevents and reverses murine cardiac hypertrophy," published in the February 2008 edition of the Journal of Clinical Investigation, researchers found that when the herb was given orally to a variety of mouse models with enlarged hearts (hypertrophy), it can prevent and reverse hypertrophy, restore heart function and reduce scar formation.

"Whether you are young or old; male or female; the larger your heart is, the higher your risk is for developing heart attacks or heart failure in the future," explains Dr. Liu, a cardiologist in the Peter Munk Cardiac Centre at the Canadian Institutes of Health Research - Institute of Circulatory and Respiratory Health. If clinical trials of curcumin support initial findings of heart enlargement prevention, it may offer hope for millions of patients with heart enlargement. Dr. Liu, who holds the Heart and Stroke Foundation's Polo Chair Professor in Medicine and Physiology at the University of Toronto, says that curcumin may be a safe and effective means of preventing heart failure in the future. This study was funded by the Heart and Stroke Foundation and the Canadian Institutes of Health Research.

"Curcumin has been the subject of extensive research over the past few years, and has been shown to protect the liver, inhibit tumors, reduce inflammation and prevent the formation of the amyloid beta plaques which cause Alzheimer's Disease. We are encouraged by yet another study that suggests the versatile curcumin may lower heart failure risk," said Steven M. Schorr, Chairman and CEO of Bioponic. "More than 5 million Americans are living with heart failure, and 550,000 new cases are diagnosed each year, according to the American Heart Association. The potential that our Curecumin(TM) product (http://www.curecumin.com) could provide a viable treatment strategy for those at risk for heart failure is very exciting. If proven effective, we may have an efficacious, cost effective, natural treatment for heart failure sufferers."

Bioponic Phytoceuticals Announces Master Distributorship with Nature's Best Covering 1,000 West Coast Retailers

MAUI, Hawaii: April 14, 2008:

Bioponic Phytoceuticals, Inc. ("Bioponic" or "the Company") (OTC: BPYT)Phyto Logo

announced today that Nature's Best, the largest privately-owned wholesaler-distributor of health and natural food products in the Natural Products industry, has been named the Company's Master Distributor covering the Western United States. Effective April 1, 2008, Nature's Best is responsible for distributing five of Bioponic's most popular consumer brands to approximately 1,000 health food stores and natural product retailers in the Western United States.

Bioponic's all natural, organic health and wellness products scheduled for distribution are: Hawaiian Healing Mist™, O-Spray™, Throat Note™, Gentle Mother™ and Noni Healing Tonic, representing a total of 11 products. Individual product descriptions may be found by visiting Bioponic's website at http://www.bioponic.com.

“We are thrilled to be represented by Nature's Best. Their well-earned reputation of bringing the finest in certified organic, natural and specialty products to retail markets is a boon for our company. This master distributorship is a unique opportunity to build upon the local and online retail success of our core skin care and wellness product lines, as well as promote our latest all-natural lines like Gentle Mother,” said Steven M. Schorr, Chairman & CEO of Bioponic.

Schorr concluded, “We anticipate solid representation across retail shelves in the Western United States, including key markets with highly favorable demographics in the state of California, will help us ramp up product revenues throughout 2008.”  

Continue reading " Bioponic Phytoceuticals Announces Master Distributorship with Nature's Best Covering 1,000 West Coast Retailers" »

Bioponic Phytoceuticals Announces Record Sales Increase of 40% for the Month of January

MAUI, Hawaii, Feb. 7 /PRNewswire-FirstCall/ -- Bioponic Phytoceuticals, Inc.  ("Bioponic" or "the Company")BPI logo (OTC: BPYT - News) today announced that sales for the month of January 2008 increased 40% compared to sales for the month of January 2007.

We achieved a record breaking month of sales in January, primarily from continued success of our Flight Spray product. We are also gaining market traction for our latest product release, an all-natural solution for baby care marketed under the Gentle Mother(TM) line," said Steven M. Schorr, Chairman & CEO of Bioponic. "Bioponic is now focused on establishing distribution relationships that will greatly expand the availability of multiple product lines, including O-Spray(TM), Throat Note(TM), Gentle Mother(TM), Hawaiian Healing Mist, and Noni Healing Tonic for placement into national health food stores and natural products retailers. Our goal is take our core product lines and position them for exponential sales growth, much like Flight Spray achieved when it gained a presence in over 1,000 points of distribution."

"We have secured an agreement with a leading wholesaler-distributor in the Natural Food industry to bring five of our all natural health and wellness product lines, representing 11 products, into 1,000 retail stores in the Western U.S. We expect the results of this distributorship, and other marketing channels, will lead to aggressive total revenue growth for Bioponic in 2008," said Schorr.

Continue reading "Bioponic Phytoceuticals Announces Record Sales Increase of 40% for the Month of January" »

Bioponic Phytoceuticals CEO Issues Letter to Shareholders

MAUI, Hawaii, Nov. 29 /PRNewswire-FirstCall/ -- Bioponic Phytoceuticals,Inc. (Pink Sheets: BPYT)BPI Logo ("Bioponic"), an innovative provider of naturalproducts and patented technology serving the Complementary AlternativeMedicine (CAM) and nutraceutical markets, issued today a letter toshareholders from CEO and Chairman Steven M. Schorr to discuss the Company'smaterial developments during 2007.

Dear Shareholders:

I have great enthusiasm about Bioponic's achievements to-date, and theoutlook for the natural products and phytochemical production industry as awhole. Pharmaceuticals derived from plants account for over $10 Billion insales in the U.S. alone, and demand for plant-derived medicinals is on therise worldwide. By 2010, global sales of nutritional preparations and naturalmedicine will top nearly $200 Billion. Bioponic has over 94 proprietaryproducts in commercial production through our unique BioresonantPhytotherapeutic(TM) formulas and our proprietary Airponic Growth System thatenables the in-house production of the highest quality health and wellnessproducts.

  --  This month, we launched Curemisinin(TM), an all-natural
        artemisinin-based treatment for malaria. Alternative anti-malaria
        medicines are in dire need in places like Africa, where every 30
        seconds a child dies of the disease. According to the World Health
        Organization (WHO), "The inappropriate use of anti-malarial drugs in
        the past century contributed to widespread resistance in the malaria
        parasite to drugs such as chloroquine, leading to rising rates of
        sickness and death. Over the past decade, a new group of
        antimalarials-- known as artemisinin-based combination
        therapies -- has brought new hope in the fight against malaria."
        (http://www.who.int/features/factfiles/malaria/en/index.html)
    --  Representatives from the American Friends of Guinea began distributing
        Curemisinin to clinics in Conakry, the capital city of Guinea, Africa.
        These human clinical trials will record the efficacy of Curemisinin,
        an important step toward partnering with WHO and other organizations
        that can aide Bioponic in bringing Curemisinin into countries where it
        is needed most.
    --  Our flagship product Flight Spray® is on the heels of a mass-market
        launch into national retail outlets, including major health food
        chains, top-name pharmacies and drug stores, beginning in the first
        quarter of 2008.
    --  Our Master Broker for the Western U.S., Active Sales and Marketing of
        Southern California, will expand our retail channels for six of our
        core product lines to 1,000 or more of the nation's top health food
        stores in the Western region. We anticipate this agreement can add
        $1.5 Million in sales to Bioponic in 2008.
    --  This month also marked the launch of our first product suite geared
        specifically for newborns and infants called Gentle Mother(TM). Gentle
        Mother, a suite of five products that treat common ailments of babies,
        is available for purchase online and will be rolled out to 1,000 or
        more national retail chains beginning in 2008.
    --  Entered into a $500,000 exclusive production and sales agreement with
        Malie, Inc. of Kauai, Hawaii to manufacture Malie's new Facial Tonic
        product line using Bioponic's proprietary ingredients and
        formulations.
    --  Received an initial order from Singapore-based Muji Global Sourcing
        Pte. Ltd. ("Muji"), who will be selling several Bioponic product lines
        throughout its established territories in Asia.
    --  Developed Curecumin(TM), a Bioresonant Phytotherapeutic(TM) formula
        designed to treat Alzheimer's Disease and the five leading forms of
        cancer (breast, colon, lung, prostate and skin cancers)
    --  Continue to develop our portfolio of intellectual properties with the
        acquisition of trademarks for our branded products and patent pending
        status for our Bioresonant Phytotherapeutic technology.

Continue reading "Bioponic Phytoceuticals CEO Issues Letter to Shareholders" »

Bioponic Phytoceuticals Introduces All Natural Baby Product Suite 'Gentle Mother'

MAUI, Hawaii, Nov. 19 /PRNewswire-FirstCall/ -- Bioponic Phytoceuticals, Inc. (Pink Sheets: BPYT - News;Gentle Mother Logo

"Bioponic"), an innovative provider of natural products and patented technology serving the Complementary Alternative Medicine (CAM) and nutraceutical markets, announced the launch of its first product suite geared specifically for newborns and infants called "Gentle Mother(TM)". Gentle Mother is comprised of five, all natural herbal remedies based on the Company's proprietary Bioresonant Phytotherapeutic(TM) formulations with easy-to-use, liquid spray delivery systems. Each product is a gentle water-based formula designed to soothe and treat common, recurring ailments such as diaper rash, teething, nasal congestion, as well as aide in digestion and sleep.

"Many parents are turning towards all natural baby formulations to avoid additives and unwanted preservatives that may cause side effects or can be detrimental to their children's health, especially over extended periods of use. Consumers are more health conscious, environmentally aware and receptive to alternative remedies than ever before. Demand for natural baby products is dramatically on the rise, and a number of the world's leading brands and grocers are clearing shelf space for 'green' baby product lines. For instance, one leading food chain has tripled the space allotted to natural baby products in just the last five years," said Steven M. Schorr, chairman and CEO of Bioponic.

Gentle Mother is currently available for purchase at http://www.bioponic.com and will soon be available in leading health food stores. According to Schorr, "We are very enthusiastic to begin marketing Gentle Mother worldwide, and in early 2008 we plan to make the entire suite available in over 1,000 health food stores. We have the distribution agreements in place to take several of our products to a national scale, and Gentle Mother is a very promising addition in our product line-up for 2008."

 

Continue reading "Bioponic Phytoceuticals Introduces All Natural Baby Product Suite 'Gentle Mother'" »

Bioponic Phytoceuticals Launches Curemisinin for the Treatment of Malaria in Guinea, Africa

MAUI, Hawaii, Nov. 13 /PRNewswire-FirstCall/ -- Bioponic Phytoceuticals, Inc. (Pink Sheets: BPYT - News;Curemisinin Bot

"Bioponic"), an innovative provider of natural products and patented technology serving the Complementary Alternative Medicine (CAM) and nutraceutical markets, announced today the launch of Curemisinin(TM), an all-natural anti-malaria product that is based on three proven effective anti-malaria herbs: Artemesia, Turmeric and Cinchona Bark, uniquely extracted through the Company's proprietary extraction/distillation technologies. This binary product comprises a nasal spray (Curemisinin A) with an oral spray (Curemisinin B) to treat malaria in the quickest, most effective manner.

Malaria is a disease caused by a blood parasite transmitted by mosquitoes, and the number one killer in sub-Saharan Africa, killing more than a million people worldwide, every year. The majority of those who die from malaria are African children, according to the Centers for Disease Control. Through Bioponic's international alliance with Hyperdynamics Corp, Curemisinin is currently being disseminated free-of-charge in clinics located in the capital city of Guinea, Africa. The efficacy of Bioponic's Curemisinin will be recorded, and provide valuable data over the next several weeks on the product's ability to treat malaria in humans.

Bioponic's Chairman and CEO Steven M. Schorr remarked, "Curemisinin's use of a nasal delivery system allows the bioresonant liquid remedy to be delivered directly to the brain via the nasal membrane. This may have a significant impact on Cerebral Malaria, a condition primarily affecting children, who die within 24 to 72 hours without treatment. Bioponic not only hopes to stop the track of cerebral malaria, but potentially help bring down the cost of treatment and increase the efficacy of treatments for all types of malaria, especially resistant strains of the disease."

 

Continue reading "Bioponic Phytoceuticals Launches Curemisinin for the Treatment of Malaria in Guinea, Africa" »

Bioponic Phytoceuticals Plans to Bring Flight Spray Product to Mass Market Retailers Nationwide Beginning in Q1 2008

MAUI, Hawaii, Nov. 1 /PRNewswire-FirstCall/ -- FS Box

Bioponic Phytoceuticals, Inc. ("Bioponic" or "the Company") (OTC: BPYT - News) today announced that it is preparing to launch a national roll-out of its nasal hydration product Flight Spray® to mass market retailers and top-name pharmacy and drug store chains beginning in the first quarter of 2008.

Flight Spray has sold over 50,000 units since its initial launch in April 2005. "We are preparing for a mass market push that has the potential to exponentially increase sales of Flight Spray during 2008," said Steven M. Schorr, chairman & CEO of Bioponic. "The early buzz on Flight Spray was that it was the next Airborne. Good Morning America and ABC Health News were among the first national media outlets to favorably compare it to Airborne. Considering Airborne sold over $100 million last year, Flight Spray could achieve similar sales success given the expansion we have planned in significantly large retail markets."

Flight Spray is currently sold in travel-related retail stores and via web sites such as Magellens.com, TravelSmith.com and Drugstore.com, and on the Company-owned FlightSpray.com. Flight Spray is also available on Amazon.com, along with 85 other Bioponic Phytoceuticals products, and at AllNaturalMerchandise.com. In Australia, Flight Spray is sold on GlobalTravelProducts.com and in the U.K. and Europe at Vocal-care.com. Flight Spray comes in a 1oz. (30ml) and .5oz (15ml) pump spray bottle and is now shelf ready in a display box.

Continue reading "Bioponic Phytoceuticals Plans to Bring Flight Spray Product to Mass Market Retailers Nationwide Beginning in Q1 2008" »

Bioponic Phytoceuticals Receives Initial Order From Singapore Distributor to Launch Asia-Pacific Retail Sales

 

BPI Logo

 

MAUI, Hawaii, Oct. 24 /PRNewswire-FirstCall/

-- Bioponic Phytoceuticals, Inc. (OTC: BPYT - News; "Bioponic"), an innovative provider of natural products and patented technology serving the Complementary Alternative Medicine (CAM) and nutraceutical markets, announced today that it received an initial order from Muji Global Sourcing Pte. Ltd. ("Muji"), a natural products retail distributor based in Singapore. Muji will distribute several Bioponic product lines, including Flight Spray(TM), Hawaiian Healing Mist(TM), Auntie Mahi Poe Poe's Healing Tonics, Noni Healing Tonic(TM) and the Noni Care collection, to reach billions of people in the Asia-Pacific region. Muji will market Bioponic products primarily in Japan, China, Malaysia, Thailand, Taiwan and Vietnam.

President of Bioponic Phytoceuticals, Steven Schorr, said, "Our Singapore distributor is expertly timed to capitalize on emerging health trends taking over Asia. Our Noni Healing Tonic is based on the Pacific noni-fruit, which has treated various diseases for hundreds of years in Hawaii, the Pacific Islands and Southeast Asia. Noni is now a much sought after ingredient throughout all regions of Asia. Medicinal uses, contemporary and worldwide, value the power of noni for the treatment of dozens of ailments from attention deficit disorder, addictions, allergies, arthritis and asthma to cardiovascular disease and digestive problems. Our Noni Healing Tonic could potentially be the catalyst that drives our Asian sales presence."

Schorr concluded, "In addition to consumer retail, Muji has experience in selling to commercial international markets, such as the airline and travel industry, which will help us establish market share for anti-infectious products like Flight Spray beginning in 2008."

Continue reading "Bioponic Phytoceuticals Receives Initial Order From Singapore Distributor to Launch Asia-Pacific Retail Sales" »

Bioponic Phytoceuticals Featured in OTC Financial Network Report

MAUI, Hawaii, Oct. 24 /PRNewswire-FirstCall/ --

Bioponic Phytoceuticals, Inc. (OTC: BPYT - News;OTCFN logo "Bioponic"), an innovative provider of natural products and patented technology serving the Complementary Alternative Medicine (CAM) and nutraceutical markets, announced today that OTC Financial Network (OTCFN), a division of National Financial Communications Corp., has issued a Corporate Facts report on the Company. The report highlights Bioponic's intellectual properties, herbal remedies and life-saving applications, retail distribution strategy and management team. Interested parties can download the report at http://www.otcfn.com/bpyt/bpyt-report.pdf or call 781-444-6100 for reprints.

Publisher of OTCFN Corporate Facts Geoffrey Eiten stated, "Bioponic produces over 94 products that utilize the Company's patented distillation and agricultural processes, which optimize the efficacy of plant-derived nutrients. The Company is on the heels of expanding its distribution channels to high-margin retailers including Whole Foods Market and over 10,000 health food stores and pharmacies. Bioponic is also incorporating key ingredients into products that can treat epidemic disease, including malaria, Alzheimer's and cancer. With its dynamic growth strategies, Bioponic has a strong platform to enhance shareholder value over the near- and long-term."

Continue reading "Bioponic Phytoceuticals Featured in OTC Financial Network Report" »

Bioponic Phytoceuticals to Roll Out Multiple Products to 1,000 Major Health Food Stores in the Western United States

MAUI, Hawaii, Oct. 16 /PRNewswire-FirstCall/ --BPI Logo

Bioponic Phytoceuticals, Inc. (OTC: BPYT - News; "Bioponic"), an innovative provider of natural products and patented technology serving the Complementary Alternative Medicine (CAM) and nutraceutical markets, announced today that it has engaged Active Sales and Marketing of Southern California as its Master Distributor covering the Western United States, including the states of California, Washington, Nevada, Arizona, Colorado, Utah, Idaho, New Mexico and Oregon.

The agreement will initially distribute six of Bioponic's most popular health and well-being products: Hawaiian Healing Mist(TM); O-Spray(TM); Throat Note(TM); Traveler's 1st Aid(TM); Noni Healing Tonic and Ginzeng! Descriptions of these products can be found at http://www.bioponic.com.

According to the Natural Foods Merchandiser, in 2006, retail channels accounted for 81%, or $46.1 billion, of total natural product sales in the U.S. Steven M. Schorr, Chairman & CEO of Bioponic, said, "With this agreement, we mark a significant new milestone in carving out an all-important U.S. retail presence beyond the local Hawaiian market."

Schorr continued, "Some of today's largest retail chains and supermarkets were founded on natural and organic product lines. Active Sales and Marketing brings established channels with the pioneers and leaders in the natural/nutraceutical market, and provides a direct path to favorable shelf space within highly trafficked major retailers. Based on our ability to bring six products to about 1,000 stores throughout 2008, we believe we can successfully generate additional sales of $1.5 million or more by the end of next year."

Continue reading "Bioponic Phytoceuticals to Roll Out Multiple Products to 1,000 Major Health Food Stores in the Western United States" »

Bioponic Phytoceuticals Retains OTC Financial Network for Investor Relations

OTCFN LogoMAUI, Hawaii, Oct. 4 /PRNewswire-FirstCall/ --

Bioponic logoBioponic Phytoceuticals, Inc. (Pink Sheets: BPYT - News; "Bioponic"), an innovative provider of natural products and patented technology serving the Complementary Alternative Medicine (CAM) and nutraceutical markets, announced today that it has retained OTC Financial Network, a division of National Financial Communications Corporation, as its investor relations representative.Sales of CAM reached $5 billion in 2005, and approximately 62% of U.S. adults are using some form of CAM for preventing and managing chronic disease, according to Med Ad News. Geoffrey Eiten, president of National Financial Communications, commented, "Bioponic has developed a patented, new natural healing modality and an extensive suite of branded product lines that serve explosive growth in alternative medicine."

Continue reading "Bioponic Phytoceuticals Retains OTC Financial Network for Investor Relations" »

Research Suggests Curecumin™ May Be an Effective Treatment for Skin Cancer

KULA, Maui, Hawaii, May 03, 2007 /PRNewswire-FirstCall/ --

Curecumin Spray Bioponic Phytoceuticals, Inc. ("Bioponic" or "the Company") today announced that its Curecumin(TM) (a Bioresonant Phytotherapeutic(R) form of curcumin in a liquid delivery system) may be an important treatment for Skin Cancer.

In a recent study published in the Journal of Biological Chemistry, "Curcumin Suppresses AP1 Transcription Factor-dependent Differentiation and Activates Apoptosis in Human Epidermal Keratinocytes," conducted at the Departments of Physiology and Biophysics, Dermatology, Biochemistry, Reproductive Biology, and Oncology, at School of Medicine in Cleveland, Ohio. Scientists concluded, "The diet-derived cancer preventive agent, curcumin, inhibits skin cancer cell proliferation and tumor formation ... We show that curcumin suppresses the differentiation agent-dependent activation of hINV gene expression and that an AP1 transcription factor DNA binding site in the hINV gene is required for this regulation ... These studies provide important insights regarding the mechanism whereby curcumin acts as a chemopreventive agent in normal human epidermis."

Continue reading "Research Suggests Curecumin™ May Be an Effective Treatment for Skin Cancer" »

Curecumin(TM) May Be an Effective Treatment for Lung Cancer

MAUI, Hawaii, March 27 /PRNewswire-FirstCall/ --Flask Curecumin

Bioponic Phytoceuticals, Inc. ("Bioponic" or "the Company") (OTC: BPYT - News) today announced that its Curecumin(TM) (a Bioresonant Phytotherapeutic® form of Turmeric containing curcumin in a liquid nasal delivery system) may be an important treatment for Lung Cancer.

In a recent study published in Science Direct, "Induction of Apoptosis in Human Lung Cancer Cells by Curcumin," conducted at the Department of Medicine, Pediatrics and Family and Preventive Medicine, School of Medicine, University of California, San Diego, scientists concluded, "Curcumin, a phenolic compound from the rhizome of the plant Curcuma longa has anti-inflammatory, antioxidant and anti-cancer activities... This study investigated the cellular and molecular changes induced by curcumin leading to the induction of apoptosis in human lung cancer cell lines -- A549 and H1299... Curcumin inhibited the growth of both the cell lines in a concentration dependent manner... Curcumin induced apoptosis in both the lung cancer cell lines."

Continue reading "Curecumin(TM) May Be an Effective Treatment for Lung Cancer" »

Curecumin™ May Be An Effective Treatment For Prostate Cancer

Curecumin bottle

 MAUI, HAWAII, Date: March 19, 2007/ PRNewswire-

Bioponic Phytoceuticals, Inc. ("Bioponic" or "the Company") (OTC PK: BPYT) today announced that its Curecumin™ (a Bioresonant Phytotherapeutic® form of Turmeric containing curcumin), may be an important treatment for Prostate Cancer.

“Curcumin, a turmeric root extract, has been shown to possess activity in the treatment and prevention of cancer, multiple sclerosis, and Alzheimer's disease” according to a 3/7/2007 article posted on UroToday.com, “The molecular mechanism for its anticancer effect is largely unknown, although it is thought to inhibit the synthesis of MDM2, an oncoprotein known to bind p53 and modulate p21 expression. In the March 1 issue of Cancer Research, Li and colleagues from the Comprehensive Cancer Center of the University of Alabama report on a study designed to elucidate the molecular anticancer effect of curcumin in a preclinical prostate cancer model.”  “curcumin was found to decrease the mRNA and protein expression of the oncoprotein MDM2 and to enhance the expression of tumor modulator p21.” “This well-performed study provides an elegant mechanistic explanation for the anticancer effect of curcumin.”

Continue reading "Curecumin™ May Be An Effective Treatment For Prostate Cancer" »

Bioponic Phytoceuticals Announces the Addition of Dr. Richard Alpert to the Board of Directors

Dr. Richard AlpertKula, Maui, Hawaii, March 6 /PRNewswire-FirstCall/ 


Bioponic Phytoceuticals, Inc. ("Bioponic" or "the Company") (OTC: BPYT) today announced that Dr. Richard Alpert, author, teacher and social visionary has joined the Company's Board of Directors. Dr. Alpert (aka Ram Dass) is a world-renowned leader in the human consciousness movement. His writings have reached millions. Born in 1931, he received a Ph.D. from Stanford University where he served on the psychology faculty (and at the University of California). From 1958 to 1963 he taught in the Department of Social Relations and the Graduate School of Education at Harvard University.

"I am delighted that someone with Dr. Alpert's wealth of experience in the Complementary Alternative Medicinal field has agreed to join the Board. He brings tremendous insight and credibility to the Company," said Steven M. Schorr, Chairman & CEO -- Bioponic Phytoceuticals, Inc.

Continue reading "Bioponic Phytoceuticals Announces the Addition of Dr. Richard Alpert to the Board of Directors" »

Bioponic Phytoceuticals Announces $500,000 Exclusive Production and Sales Agreement with Malie, Inc.

Maile Renew KULA, MAUI, HAWAII, Date: January 25, 2007 /PRNewswire-

Bioponic Phytoceuticals, Inc. ("Bioponic" or "the Company") (OTC PK: BPYT) today announced that an agreement has been signed with Malie, Inc. of Kauai, Hawaii for the exclusive production of Malie’s new Facial Tonic product line using Bioponic’s proprietary ingredients and formulations. The Company anticipates that the contract will develop into a long-term, multi-million dollar opportunity for its specialized distillation/extraction production capabilities.

The line, currently in production, includes four facial tonics: Rescue (formulated with extractions of Hawaiian grown herbs including -Lilikoi and Lemon Grass); Renew (Ginger and Lime); Purify (Guava and Pineapple); and Beautify (Jasmine and Rose). These products, now being introduced to the Health and Beauty Aid, and spa markets have been featured at the International SPA Association show at Las Vegas, Nevada.


Continue reading "Bioponic Phytoceuticals Announces $500,000 Exclusive Production and Sales Agreement with Malie, Inc." »

Bioponic Phytoceuticals Announces that its Curecumin™ Product May Be An Effective Treatment For Alzheimer’s Disease

KULA, MAUI, HAWAII, Date: January 22, 2007 /PRNewswire-Curecumin Nasal Sray

Bioponic Phytoceuticals, Inc. ("Bioponic" or "the Company") (OTC PK: BPYT) today announced that its Curecumin™ product (a Bioresonant Phytotherapeutic™ form of Turmeric) may be an important treatment and/or preventative for Alzheimer’s Disease.

UCLA/VA researchers found that curcumin (an active compound found in Turmeric) may help the immune system clear the brain of the amyloid beta plaques found in Alzheimer's disease patients. Recently published in the Journal of Alzheimer's Disease the findings may lead to a new approach in treating Alzheimer's disease by enhancing the natural function of the immune system using curcumin, known for its anti-inflammatory and anti-oxidant properties. According to a research study conducted at UCLA Alzheimer’s Disease Research Center, ”There is substantial in-vitro data indicating that curcumin is a promising agent in the treatment and/or prevention of AD.”

Continue reading "Bioponic Phytoceuticals Announces that its Curecumin™ Product May Be An Effective Treatment For Alzheimer’s Disease" »

Special Status Granted To Bioponic Phytoceuticals Patent Application

KULA, MAUI, HAWAII, Date: January 10, 2007  /PRNewswire-/ 

Bioponic Phytoceuticals, Inc.. ("Bioponic" or "the Company") (OTC PK: BPYT) today announced that its utility patent application “Method of Making Phytotherapeutic Hydrosols” has been granted a “Petition To Make Special” by the United States Patent And Trademark Office. “The petition requests that the application be made special under the accelerated examination procedure set forth in M.P.E.P. 708.02 Section XII: Special status for Applications relating to BIOTECHNOLOGY FIELD.”

Continue reading "Special Status Granted To Bioponic Phytoceuticals Patent Application" »

Flight Spray® can fly! Bioponic Phytoceuticals announces its Flight Spray nasal hydration product qualifies under new rules for an exemption from the TSA terrorist plot ban.

Flight SprayMAUI, HAWAII, Date: August 14, 2006 /PRNewswire- /

Bioponic Phytoceuticals, Inc. ("Bioponic" or "the Company") (OTC PK: BPYT) today announced that new rules established by the Transportation Safety Administration (“TSA”) on Sunday August 13, 2006 allows for the exemption of Flight Spray from the recently established ban on passengers carrying liquids onto flights. Flight Spray can be used on airplane flights throughout the United States.

Continue reading "Flight Spray® can fly! Bioponic Phytoceuticals announces its Flight Spray nasal hydration product qualifies under new rules for an exemption from the TSA terrorist plot ban." »

Bioponic Phytoceuticals™ Chairman & CEO Steven M. Schorr discusses corporate plans and strategies in interviews on CEOCast.com and WallstreetReporter.com

MAUI, HAWAII, Date: August 1, 2006 /PRNewswire- 

Bioponic Phytoceuticals, Inc. ("Bioponic" or "the Company") (OTC PK: BPYT) today announced that its Chairman and CEO Steven M. Schorr is featured on both the CEOCast.com and WallstreetReporter.com investor relations web sites.

Continue reading "Bioponic Phytoceuticals™ Chairman & CEO Steven M. Schorr discusses corporate plans and strategies in interviews on CEOCast.com and WallstreetReporter.com" »

Bioponic Phytoceuticals Announces Research Agreement With Pediatric Neurosurgery and Childhood Hydrocephalus Center's Dr. J. Pattisapu.

MAUI, HAWAII, Date: July 27, 2006 /PRNewswire- /

Bioponic Phytoceuticals, Inc. ("Bioponic" or "the Company") (OTC: BPYT - News) today announced that it has signed an agreement with Pediatric Neurosurgery and Childhood Hydrocephalus Center's principal Dr. Jogi Pattisapu to research a treatment for Childhood Hydrocephalus using the Company's Curecumin(TM) product.

Continue reading "Bioponic Phytoceuticals Announces Research Agreement With Pediatric Neurosurgery and Childhood Hydrocephalus Center's Dr. J. Pattisapu." »

Bioponic Phytoceuticals Announces the Availability of All of Its Bioresonant Phytotherapeutic Products for Sale on Amazon.com's Online Stores

MAUI, Hawaii, June 27 /PRNewswire-FirstCall/ --

Bioponic Phytoceuticals, Inc. ("Bioponic" or "the Company") (OTC: BPYT - News) today announced that all of its 11 product lines covering 83 products will be immediately available for sale on Amazon.com's online stores.

Continue reading "Bioponic Phytoceuticals Announces the Availability of All of Its Bioresonant Phytotherapeutic Products for Sale on Amazon.com's Online Stores" »

Bioponic Phytoceuticals announces commencement of trading on the NASDAQ Pink Sheets

KULA, MAUI, HAWAII, Date June 5, 2006 /PRNewswire-FirstCall/ -


Bioponic Phytoceuticals, Inc. ("Bioponic" or "the Company") (OTC PK: BPYT) today announced that Shares of Bioponic Phytoceuticals, Inc.’s common stock will be traded on the Nasdaq Pink Sheets Market under the trading symbol "BPYT".

Continue reading "Bioponic Phytoceuticals announces commencement of trading on the NASDAQ Pink Sheets" »